📰 Athersys Healios News

Athersys Healios News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Athersys Healios. Real-time updates on events, politics, business and more.

Acute Ischemic Stroke Market is Expected to Showcase Significant Growth at a CAGR of 10.6% During the Study Period (2019-2032), Predicts DelveInsight

May 9, 2023

/PRNewswire/ -- DelveInsights Acute Ischemic Stroke Market Insights report includes a comprehensive understanding of current treatment practices, acute...

United Kingdom United States Shruti Thakur Athersys Healios Asundexian Bayer Bristol Myers Squibb Janssen

Source: prnewswire.com

DelveInsight Business Research, LLP: Acute Ischemic Stroke Market is Expected to Showcase Significant Growth at a CAGR of 10.6% During the Study Period (2019-2032), Predicts DelveInsight

May 9, 2023

The dynamics of the acute ischemic stroke (AIS) market are anticipated to change during the forecast period (2023-2032) owing to the improved knowledge of stroke pathophysiology, awareness of

United Kingdom United States Shruti Thakur Athersys Healios Asundexian Bayer Bristol Myers Squibb Janssen

Source: finanznachrichten.de

DelveInsight Business Research, LLP: Extremely Robust Acute Respiratory Distress Syndrome Pipeline Featuring 100+ Companies Expected to Change the Pace of the ARDS Treatment

March 30, 2023

The rise in the incidence of ARDS stimulates the research and development of the drug, as it is likely to provide an appropriate environment for newer products to be profitable. Companies across

Prnewswire Delveinsight Inflammtory Demyelinating Polyneuropathy Verona Pharma Boehringer Ingelheim Genentech Synact Pharma Sarconeos Zavegepant

Source: finanznachrichten.de

Extremely Robust Acute Respiratory Distress Syndrome Pipeline Featuring 100+ Companies Expected to Change the Pace of the ARDS Treatment

March 30, 2023

The rise in the incidence of ARDS stimulates the research and development of the drug, as it is likely to provide an appropriate environment for newer products...

Synact Pharma Athersys Healios Verona Pharma Sarconeos Zavegepant Boehringer Ingelheim Genentech Chiesi Farmaceutici